Avantor, Inc.
AVTR
Rangering i aksjer
#1889
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania,... Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
Aksjekurs
$16.64
Markedsverdi
$11.25B
Endring (1 dag)
2.12%
Endring (1 år)
9.58%
Land
US
Handel Avantor, Inc. (AVTR)
Kategori
Healthcare
P/E-forhold for Avantor, Inc. (AVTR)
P/E-forhold per October 2026 TTM: -18.72
Ifølge Avantor, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) -18.72. Ved slutten av 2023 hadde selskapet en P/E på 48.03.
P/E-forholdshistorikk for Avantor, Inc. fra 2015 til 2026
P/E-forhold ved slutten av hvert år
| År | P/E-forhold | Endre |
|---|---|---|
| 2026 (TTM) | -18.72 | -192.89% |
| 2024 | 20.15 | -58.06% |
| 2023 | 48.03 | 140.22% |
| 2022 | 20.00 | -53.99% |
| 2021 | 43.46 | -68.77% |
| 2020 | 139.13 | -27.78% |
| 2019 | 192.64 | -332.53% |
| 2018 | -82.85 | 29.69% |
| 2017 | -63.88 | -61.98% |
| 2016 | -168.02 | -146.84% |
| 2015 | 358.67 | 0.00% |
P/E-forhold for lignende selskaper eller konkurrenter
| Selskap | P/E-forhold | Forskjell i P/E-forhold | Land |
|---|---|---|---|
| 47.48 | -353.70% |
US
|
|
| 27.43 | -246.53% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | -403.97% |
US
|
|
| - | - |
CH
|
Hvordan lese en P/E-ratio?
Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.
Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.
Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.